Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
EHA 2025
Breaking barriers in sickle cell disease management: pyruvate kinase activation for red blood cell metabolism
EHA 2025
EHA 2025
12 - 15 June 2025
Breaking barriers in sickle cell disease management: pyruvate kinase activation for red blood cell metabolism
Share
Copy link
{{pageUrl}}
Keywords
Rare Blood Disorders
Congress industry session
Etavopivat
PHASE 2 (RCT)
